Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Shabrova, Elena V ^a,d   Tarnopolsky, Olga ^a   Singh, Ajay P ^a   Plutzky, Jorge ^b   Vorsa, Nicholi ^a,c   Quadro, Loredana ^d  

^a School of Environmental and Biological Sciences   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTILIPEMIC AGENT; FLAVONOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; ADIPONECTIN RECEPTOR; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OBESITY; PROTEIN DETERMINATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; CRANBERRY; GENETICS; GLUCOSE BLOOD LEVEL; HEALTH; HUMAN; ISOLATION AND PURIFICATION; LIVER; METABOLISM; MOUSE MUTANT; MUSCLE; ORGAN SIZE; PATHOLOGY; PHOSPHORYLATION;

MUS; VACCINIUM MACROCARPON;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DOWN-REGULATION; FLAVONOIDS; HEALTH; HUMANS; INTRA-ABDOMINAL FAT; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MUSCLES; OBESITY; ORGAN SIZE; PHOSPHORYLATION; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; VACCINIUM MACROCARPON;

EID: 80053925412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024634     Document Type: Article

References (86)

1. Barnes S, Prasain J, (2005) Current progress in the use of traditional medicines and nutraceuticals. Curr Opin Plant Biol 8: 324-328.
2. Liu RH, (2003) Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78: 517S-520S.
3. Williams RJ, Spencer JP, Rice-Evans C, (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36: 838-849.
4. Pappas E, Schaich KM, (2009) Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Crit Rev Food Sci Nutr 49: 741-781.
5. Masella R, Di Benedetto R, Vari R, Filesi C, Giovannini C, (2005) Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 16: 577-586.
6. Despres JP, (2007) Cardiovascular disease under the influence of excess visceral fat. Crit Pathw Cardiol 6: 51-59.
7. Trayhurn P, Beattie JH, (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329-339.
8. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
9. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, et al. (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76: 560-568.
10. Yamamoto Y, Oue E, (2006) Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet. Biosci Biotechnol Biochem 70: 933-939.
11. Jayaprakasam B, Olson LK, Schutzki RE, Tai MH, Nair MG, (2006) Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem 54: 243-248.
12. Rasmussen SE, Frederiksen H, Struntze Krogholm K, Poulsen L, (2005) Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res 49: 159-174.
13. Liburt NR, McKeever KH, Streltsova JM, Franke WC, Gordon ME, et al. (2009) Effects of ginger and cranberry extracts on the physiological response to exercise and markers of inflammation in horses. Comparative Exercise Physiology 6: 157-169.
14. Reimer MK, Ahren B, (2002) Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 51 (Suppl 1): S138-143.
15. Lin S, Thomas TC, Storlien LH, Huang XF, (2000) Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 24: 639-646.
16. Ortiz B, Wassef L, Shabrova E, Cordeddu L, Banni S, et al. (2009) Hepatic retinol secretion and storage are altered by dietary CLA: common and distinct actions of CLA c9,t11 and t10,c12 isomers. J Lipid Res 50: 2278-2289.
17. Council N, (1996) Guide for the Care and Use of Laboratory Animals. D.C.: National Academy Press.
18. Wang CY, Chang TC, (2004) Non-HDL cholesterol level is reliable to be an early predictor for vascular inflammation in type 2 diabetes mellitus. J Clin Endocrinol Metab 89: 4762-4767.
19. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
20. Hayashida K, Takeuchi T, Ozaki T, Shimizu H, Ando K, et al. (2004) Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats. Am J Physiol Regul Integr Comp Physiol 286: R359-365.
21. Qiao L, Zou C, van der Westhuyzen DR, Shao J, (2008) Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes 57: 1824-1833.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
23. Unger RH, (2000) Leptin physiology: a second look. Regul Pept 92: 87-95.
24. Wang Y, Xu A, Knight C, Xu LY, Cooper GJ, (2002) Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 277: 19521-19529.
25. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB, (2006) Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8: 264-280.
26. Wang Y, Lam KS, Yau MH, Xu A, (2008) Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 409: 623-633.
27. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, et al. (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94: e27-31.
28. Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE, (2008) Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149: 2270-2282.
29. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS, (2008) Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 8: 512-521.
30. Wang H, Eckel RH, (2009) Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 297: E271-288.
31. Desvergne B, Michalik L, Wahli W, (2006) Transcriptional regulation of metabolism. Physiol Rev 86: 465-514.
32. Vega RB, Huss JM, Kelly DP, (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20: 1868-1876.
33. Holloway GP, Perry CG, Thrush AB, Heigenhauser GJ, Dyck DJ, et al. (2008) PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein. Am J Physiol Endocrinol Metab 294: E1060-1069.
34. Gimeno RE, (2007) Fatty acid transport proteins. Curr Opin Lipidol 18: 271-276.
35. Qi C, Zhu Y, Reddy JK, (2000) Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell Biochem Biophys 32 Spring pp. 187-204.
36. McGarry JD, Brown NF, (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244: 1-14.
37. Brand MD, Esteves TC, (2005) Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2: 85-93.
38. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124.
39. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
40. Acin-Perez R, Hoyos B, Zhao F, Vinogradov V, Fischman DA, et al. (2010) Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. Faseb J 24: 627-636.
41. Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, et al. (2006) AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun 340: 291-295.
42. Miyoshi H, Souza SC, Zhang HH, Strissel KJ, Christoffolete MA, et al. (2006) Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and-independent mechanisms. J Biol Chem 281: 15837-15844.
43. Pietta PG, (2000) Flavonoids as antioxidants. J Nat Prod 63: 1035-1042.
44. Briskin DP, (2000) Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. Plant Physiol 124: 507-514.
45. Bhagwat S, Gebhardt S, Haytowitz D, Holden J, Harnly J, (2006) USDA database for the flavonoid content of selected foods. Release 2. Beltsville, Maryland 20705.
46. Decorde K, Teissedre PL, Sutra T, Ventura E, Cristol JP, et al. (2009) Chardonnay grape seed procyanidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers. Mol Nutr Food Res 53: 659-666.
47. Nagasako-Akazome Y, Kanda T, Ohtake Y, Shimasaki H, Kobayashi T, (2007) Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index. J Oleo Sci 56: 417-428.
48. Rao TP, Sakaguchi N, Juneja LR, Wada E, Yokozawa T, (2005) Amla (Emblica officinalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats. J Med Food 8: 362-368.
49. Terra X, Montagut G, Bustos M, Llopiz N, Ardevol A, et al. (2009) Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J Nutr Biochem 20: 210-218.
50. Barnea M, Shamay A, Stark AH, Madar Z, (2006) A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 14: 2145-2153.
51. Naderali EK, Estadella D, Rocha M, Pickavance LC, Fatani S, et al. (2003) A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue. Clin Sci (Lond) 105: 403-408.
52. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, et al. (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279: 12152-12162.
53. Frizzell N, Rajesh M, Jepson MJ, Nagai R, Carson JA, et al. (2009) Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin. J Biol Chem 284: 25772-25781.
54. Nagai R, Brock JW, Blatnik M, Baatz JE, Bethard J, et al. (2007) Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress. J Biol Chem 282: 34219-34228.
55. Moskaug JO, Carlsen H, Myhrstad MC, Blomhoff R, (2005) Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 81: 277S-283S.
56. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, et al. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085.
57. Guerre-Millo M, (2008) Adiponectin: an update. Diabetes Metab 34: 12-18.
58. Hardie DG, (2004) The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117: 5479-5487.
59. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, et al. (2006) Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55: 2562-2570.
60. Jager S, Handschin C, St-Pierre J, Spiegelman BM, (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 104: 12017-12022.
61. Kliewer SA, Xu HE, Lambert MH, Willson TM, (2001) Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 56: 239-263.
62. Barger PM, Browning AC, Garner AN, Kelly DP, (2001) p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol Chem 276: 44495-44501.
63. Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC, Staels B, (2002) Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 16: 1013-1028.
64. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, et al. (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464: 1313-1319.
65. Rader DJ, (2003) Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol 92: 42J-49J.
66. Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, et al. (2009) Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men. J Clin Endocrinol Metab 94: 989-997.
67. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT, (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55: 249-259.
68. Verges B, Petit JM, Duvillard L, Dautin G, Florentin E, et al. (2006) Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol 26: 1364-1369.
69. Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J, (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295: E1323-1332.
70. Argaud D, Zhang Q, Pan W, Maitra S, Pilkis SJ, et al. (1996) Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5′-flanking sequence. Diabetes 45: 1563-1571.
71. Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, et al. (2006) Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 4: 75-87.
72. Palanivel R, Sweeney G, (2005) Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett 579: 5049-5054.
73. Ng TW, Watts GF, Farvid MS, Chan DC, Barrett PH, (2005) Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes 54: 795-802.
74. Spady DK, Dietschy JM, (1983) Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J Lipid Res 24: 303-315.
75. Clarke PR, Hardie DG, (1990) Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. Embo J 9: 2439-2446.
76. Getz GS, Reardon CA, (2006) Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 26: 242-249.
77. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93: 693-704.
78. Shockley KR, Witmer D, Burgess-Herbert SL, Paigen B, Churchill GA, (2009) Effects of atherogenic diet on hepatic gene expression across mouse strains. Physiol Genomics 39: 172-182.
79. Yang J, Goldstein JL, Hammer RE, Moon YA, Brown MS, et al. (2001) Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc Natl Acad Sci U S A 98: 13607-13612.
80. Vance DE, Vance JE, (2002) Biochemistry of lipids, lipoproteins, and membranes. Amsterdam; Boston: Elsevier. pp. 607 xxix.
81. Yang DJ, Chang YY, Hsu CL, Liu CW, Lin YL, et al. (2010) Antiobesity and hypolipidemic effects of polyphenol-rich longan (Dimocarpus longans Lour.) flower water extract in hypercaloric-dietary rats. J Agric Food Chem 58: 2020-2027.
82. Bursill CA, Abbey M, Roach PD, (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193: 86-93.
83. Tran TT, Yamamoto Y, Gesta S, Kahn CR, (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7: 410-420.
84. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122.
85. Xu A, Wang H, Hoo RL, Sweeney G, Vanhoutte PM, et al. (2009) Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology 150: 625-633.
86. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, et al. (2006) Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr 96: 357-364.